+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Deep Hyperthermia Devices Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6281284
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Deep Hyperthermia Devices: Executive Summary

Deep hyperthermia devices are used to raise the temperature of targeted tissues as part of therapeutic protocols, particularly in oncology and selected rehabilitation or pain-management applications. Their adoption depends on clinical evidence, treatment-center capabilities, regulatory requirements, reimbursement conditions, and the availability of trained personnel. The market is therefore shaped by both device performance and the broader healthcare infrastructure needed to deliver controlled thermal treatment safely.

Clinical Integration Is Reshaping Device Adoption

The landscape is shifting from stand-alone equipment procurement toward integrated care pathways combining imaging, treatment planning, temperature monitoring, and multidisciplinary clinical oversight. Hospitals and specialist centers increasingly evaluate devices according to workflow compatibility, patient selection, treatment reproducibility, cybersecurity, service support, and evidence generated in routine practice. These priorities favor systems that can be incorporated into established oncology and hospital information environments while maintaining precise thermal control and documented safety procedures.

Artificial Intelligence Strengthens Planning, Monitoring, and Operations

Artificial intelligence can support deep hyperthermia through image-assisted treatment planning, patient-specific energy modeling, adaptive control, anomaly detection, and automated documentation. Its practical value depends on high-quality clinical data, validated algorithms, interoperable systems, and transparent human oversight. Healthcare providers should distinguish decision-support applications from autonomous control, validate performance across patient populations, and establish governance for data privacy, model drift, explainability, and accountability before deploying AI-enabled workflows.

Regional Insights: Infrastructure and Evidence Shape Market Development

North America is characterized by advanced cancer-care infrastructure, demanding evidence standards, and emphasis on reimbursement and health-system integration. Europe combines established specialist capabilities with regulatory and procurement requirements that vary across national systems, while the European Union places added importance on conformity, clinical documentation, and data governance. Asia-Pacific presents diverse conditions, ranging from sophisticated tertiary hospitals to infrastructure-constrained settings, with Japan, China, South Korea, India, and Australia reflecting different pathways for clinical adoption. Latin America is influenced by uneven access to specialist oncology services, import requirements, and concentration of advanced care in major urban centers. The Middle East is developing specialized healthcare capacity through hospital investment and medical-city programs, whereas Africa faces substantial constraints in equipment access, maintenance, workforce availability, and referral networks.

Group Insights: Cooperation and Regulation Influence Deployment

ASEAN markets require approaches that account for varied regulatory systems, healthcare financing, and specialist capacity across member states. BRICS countries represent diverse health-system structures and industrial capabilities, creating opportunities for local service development alongside significant differences in access and procurement. The European Union emphasizes coordinated regulatory compliance, clinical evidence, and cross-border data considerations. G7 health systems generally place strong weight on safety, health technology assessment, cybersecurity, and integration with established clinical workflows. GCC countries are investing in advanced healthcare infrastructure but continue to require local workforce development and sustainable service models. NATO members span mature and emerging health systems, with resilience, secure digital infrastructure, and continuity of medical services gaining importance.

Country Insights: Adoption Priorities Differ Across Healthcare Systems

Australia and Canada must address geographic dispersion and concentration of specialist services, while the United States places strong emphasis on clinical evidence, reimbursement pathways, and hospital economics. Brazil and Mexico face regional disparities in oncology access and the need for dependable maintenance and training models. China is expanding advanced hospital capabilities while balancing regulatory compliance, localization, and clinical validation. India’s opportunity is linked to tertiary-care growth, affordability, and workforce development. Japan and South Korea have technologically advanced healthcare environments with demanding standards for clinical integration and operational precision. France, Germany, Italy, Spain, and the United Kingdom are shaped by public-system procurement, evidence requirements, and differing reimbursement and referral structures. Russia’s deployment conditions are influenced by healthcare infrastructure, regulatory processes, supply continuity, and access to specialized technical support.

Priorities for Leaders: Build Evidence, Integration, and Service Capability

Industry leaders should prioritize prospective clinical evidence, clearly defined treatment protocols, and transparent reporting of safety and patient outcomes. Devices should be designed for interoperability with imaging, oncology information systems, and hospital cybersecurity controls. Commercial strategies should reflect local reimbursement and procurement realities rather than relying on equipment sales alone. Long-term service agreements, preventive maintenance, operator training, and remote technical support are essential for dependable utilization, particularly outside major specialist centers. Leaders should also establish AI governance early, including validation, monitoring, documentation, and mechanisms for clinician override. Partnerships with hospitals, academic centers, and professional societies can help translate technical performance into credible clinical adoption.

Research Methodology: Evidence-Led Market Assessment

This executive summary uses the defined market scope of deep hyperthermia devices and synthesizes qualitative considerations relevant to technology adoption, clinical integration, regulation, infrastructure, workforce capability, reimbursement, and regional healthcare variation. Regional, group, and country perspectives are organized around structural conditions that influence deployment rather than numerical market estimates. Claims are framed conservatively and should be validated against current regulatory records, peer-reviewed clinical literature, procurement documentation, reimbursement policies, and direct interviews with qualified healthcare stakeholders before investment or operational decisions are made.

Conclusion: Sustainable Adoption Depends on Clinical Value and Execution

Deep hyperthermia devices are most likely to achieve durable adoption when they demonstrate clinically meaningful value within coordinated care pathways. Success depends on more than thermal performance: providers also require reliable workflows, trained teams, robust service support, compliant data practices, and evidence that supports reimbursement and procurement. Organizations that combine disciplined clinical validation with interoperable technology, responsible AI use, and region-specific implementation planning will be better positioned to expand access while maintaining treatment quality and patient safety.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Deep Hyperthermia Devices Market, by Modality
7.1. Introduction
7.2. External Hyperthermia
7.3. Interstitial Hyperthermia
7.4. Intracavitary Hyperthermia
8. Deep Hyperthermia Devices Market, by Energy Source
8.1. Introduction
8.2. Magnetic
8.3. Ultrasound
8.4. Radiofrequency
8.5. Photon Based
8.6. Microwave
9. Deep Hyperthermia Devices Market, by Product Type
9.1. Introduction
9.2. Accessories And Consumables
9.3. Applicators And Antennae
9.4. Power Generators
9.5. Thermometry And Monitoring Systems
10. Deep Hyperthermia Devices Market, by Treatment Delivery
10.1. Introduction
10.2. Combination Therapies
10.3. Intracavitary Delivery
10.4. Minimally Invasive Interstitial Delivery
10.5. Noninvasive External Delivery
11. Deep Hyperthermia Devices Market, by Application
11.1. Introduction
11.2. Non Oncological
11.2.1. Pain Management
11.2.2. Refractory Infections
11.2.3. Wound Healing
11.3. Oncological Indications
11.3.1. Brain Tumors
11.3.2. Breast Cancer
11.3.3. Cervical Cancer
11.3.4. Liver Cancer
11.3.5. Prostate Cancer
11.3.6. Rectal Cancer
12. Deep Hyperthermia Devices Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Deep Hyperthermia Devices Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Deep Hyperthermia Devices Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alba Hyperthermia System S.r.l.
16.2. Andromedic S.r.l.
16.3. BoHua Medical Co., Ltd.
16.4. Celsius42 GmbH
16.5. Chongqing Haifu Medical Technology Co., Ltd.
16.6. Combat Medical Ltd.
16.7. ElmediX NV
16.8. Gamida Cell Ltd.
16.9. Hunan Huayuan Medical Device Co., Ltd.
16.10. Hydrosun Medizintechnik GmbH
16.11. Jilin Orestep Medical Equipment Co., Ltd.
16.12. MagForce AG
16.13. Meditherm, Inc.
16.14. Nanjing Greathope Technology Co., Ltd.
16.15. Nanoprobes, Inc.
16.16. Novavida S.A.
16.17. Oncotherm Kft.
16.18. OrienTech Co., Ltd.
16.19. Perseon Corporation
16.20. Pyrexar Medical, Inc.
16.21. RanD S.r.l.
16.22. Sensius B.V.
16.23. Shanghai Huayuan Medical Equipment Co., Ltd.
16.24. Xianke Medical Equipment Co., Ltd.
16.25. Yamamoto Vinita Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Deep Hyperthermia Devices Market, Years Considered for the Study
FIGURE 2. Global Deep Hyperthermia Devices Market, Research Design
FIGURE 3. Global Deep Hyperthermia Devices Market, Research Framework
FIGURE 4. Global Deep Hyperthermia Devices Market, Data Triangulation
FIGURE 5. Global Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Deep Hyperthermia Devices Market Size, by Modality, 2025 vs 2032 (%)
FIGURE 7. Global Deep Hyperthermia Devices Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Deep Hyperthermia Devices Market Size, by Energy Source, 2025 vs 2032 (%)
FIGURE 9. Global Deep Hyperthermia Devices Market Size, by Energy Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Deep Hyperthermia Devices Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 11. Global Deep Hyperthermia Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2025 vs 2032 (%)
FIGURE 13. Global Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Deep Hyperthermia Devices Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Deep Hyperthermia Devices Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Deep Hyperthermia Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Deep Hyperthermia Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Deep Hyperthermia Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Deep Hyperthermia Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Deep Hyperthermia Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Deep Hyperthermia Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Deep Hyperthermia Devices Market Segmentation & Coverage
TABLE 2. Global Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 4. Global External Hyperthermia Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global External Hyperthermia Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global External Hyperthermia Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Interstitial Hyperthermia Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Interstitial Hyperthermia Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Interstitial Hyperthermia Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Intracavitary Hyperthermia Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Intracavitary Hyperthermia Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Intracavitary Hyperthermia Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 14. Global Magnetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Magnetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Magnetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Radiofrequency Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Radiofrequency Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Radiofrequency Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Photon Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Photon Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Photon Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Microwave Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Microwave Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Microwave Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 30. Global Accessories And Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Accessories And Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Accessories And Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Applicators And Antennae Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Applicators And Antennae Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Applicators And Antennae Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Power Generators Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Power Generators Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Power Generators Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Thermometry And Monitoring Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Thermometry And Monitoring Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Thermometry And Monitoring Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 43. Global Combination Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Combination Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Combination Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Intracavitary Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Intracavitary Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Intracavitary Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Minimally Invasive Interstitial Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Minimally Invasive Interstitial Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Minimally Invasive Interstitial Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Noninvasive External Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Noninvasive External Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Noninvasive External Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 56. Global Non Oncological Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Non Oncological Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Non Oncological Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Pain Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Pain Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Pain Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Refractory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Refractory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Refractory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Wound Healing Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Wound Healing Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Wound Healing Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Oncological Indications Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Oncological Indications Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Oncological Indications Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Brain Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Brain Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Brain Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Cervical Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Cervical Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Cervical Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Liver Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Liver Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Liver Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Rectal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Rectal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Rectal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Deep Hyperthermia Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Deep Hyperthermia Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 98. North America Deep Hyperthermia Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. North America Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 100. North America Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 101. North America Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. North America Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 103. North America Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. North America Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 105. North America Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 106. Latin America Deep Hyperthermia Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Latin America Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 108. Latin America Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 109. Latin America Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. Latin America Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 111. Latin America Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Latin America Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 113. Latin America Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 114. Europe Deep Hyperthermia Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Europe Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 116. Europe Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 117. Europe Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. Europe Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 119. Europe Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Europe Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 121. Europe Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 122. Middle East Deep Hyperthermia Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Middle East Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 124. Middle East Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 125. Middle East Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. Middle East Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 127. Middle East Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. Middle East Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 129. Middle East Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 130. Africa Deep Hyperthermia Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Africa Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 132. Africa Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 133. Africa Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. Africa Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 135. Africa Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Africa Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 137. Africa Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 138. Global Deep Hyperthermia Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. ASEAN Deep Hyperthermia Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. ASEAN Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 141. ASEAN Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 142. ASEAN Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. ASEAN Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 144. ASEAN Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. ASEAN Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 146. ASEAN Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 147. GCC Deep Hyperthermia Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. GCC Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 149. GCC Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 150. GCC Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. GCC Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 152. GCC Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. GCC Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 154. GCC Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 155. European Union Deep Hyperthermia Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. European Union Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 157. European Union Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 158. European Union Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 159. European Union Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 160. European Union Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. European Union Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 162. European Union Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 163. BRICS Deep Hyperthermia Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. BRICS Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 165. BRICS Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 166. BRICS Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. BRICS Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 168. BRICS Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. BRICS Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 170. BRICS Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 171. G7 Deep Hyperthermia Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. G7 Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 173. G7 Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 174. G7 Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. G7 Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 176. G7 Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. G7 Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 178. G7 Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 179. NATO Deep Hyperthermia Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. NATO Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 181. NATO Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 182. NATO Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. NATO Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 184. NATO Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. NATO Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 186. NATO Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 187. Global Deep Hyperthermia Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 188. United States Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 189. United States Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 190. United States Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 191. United States Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. United States Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 193. United States Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. United States Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 195. United States Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 196. Canada Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 197. Canada Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 198. Canada Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 199. Canada Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Canada Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 201. Canada Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Canada Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 203. Canada Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 204. Mexico Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 205. Mexico Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 206. Mexico Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 207. Mexico Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. Mexico Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 209. Mexico Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Mexico Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 211. Mexico Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 212. Brazil Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 213. Brazil Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 214. Brazil Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 215. Brazil Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Brazil Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 217. Brazil Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Brazil Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 219. Brazil Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 220. United Kingdom Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 221. United Kingdom Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 222. United Kingdom Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 223. United Kingdom Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. United Kingdom Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 225. United Kingdom Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. United Kingdom Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 227. United Kingdom Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 228. Germany Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 229. Germany Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 230. Germany Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 231. Germany Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Germany Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 233. Germany Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Germany Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 235. Germany Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 236. France Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 237. France Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 238. France Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 239. France Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. France Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 241. France Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. France Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 243. France Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 244. Russia Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 245. Russia Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 246. Russia Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 247. Russia Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. Russia Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 249. Russia Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Russia Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 251. Russia Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 252. Italy Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 253. Italy Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 254. Italy Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 255. Italy Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. Italy Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 257. Italy Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Italy Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 259. Italy Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 260. Spain Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 261. Spain Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 262. Spain Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 263. Spain Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. Spain Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 265. Spain Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. Spain Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 267. Spain Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 268. China Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 269. China Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 270. China Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 271. China Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. China Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 273. China Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. China Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 275. China Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 276. India Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 277. India Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 278. India Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 279. India Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 280. India Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 281. India Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. India Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 283. India Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 284. Japan Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 285. Japan Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 286. Japan Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 287. Japan Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. Japan Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 289. Japan Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Japan Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 291. Japan Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 292. Australia Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 293. Australia Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 294. Australia Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 295. Australia Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. Australia Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 297. Australia Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. Australia Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 299. Australia Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 300. South Korea Deep Hyperthermia Devices Market Size, 2017-2032 (USD Million)
TABLE 301. South Korea Deep Hyperthermia Devices Market Size, by Modality, 2017-2032 (USD Million)
TABLE 302. South Korea Deep Hyperthermia Devices Market Size, by Energy Source, 2017-2032 (USD Million)
TABLE 303. South Korea Deep Hyperthermia Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 304. South Korea Deep Hyperthermia Devices Market Size, by Treatment Delivery, 2017-2032 (USD Million)
TABLE 305. South Korea Deep Hyperthermia Devices Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. South Korea Deep Hyperthermia Devices Market Size, by Non Oncological, 2017-2032 (USD Million)
TABLE 307. South Korea Deep Hyperthermia Devices Market Size, by Oncological Indications, 2017-2032 (USD Million)
TABLE 308. Global Deep Hyperthermia Devices Market Share, by Key Player, 2025
TABLE 309. Global Deep Hyperthermia Devices Market, Key Experts

Companies Mentioned

  • Alba Hyperthermia System S.r.l.
  • Andromedic S.r.l.
  • BoHua Medical Co., Ltd.
  • Celsius42 GmbH
  • Chongqing Haifu Medical Technology Co., Ltd.
  • Combat Medical Ltd.
  • ElmediX NV
  • Gamida Cell Ltd.
  • Hunan Huayuan Medical Device Co., Ltd.
  • Hydrosun Medizintechnik GmbH
  • Jilin Orestep Medical Equipment Co., Ltd.
  • MagForce AG
  • Meditherm, Inc.
  • Nanjing Greathope Technology Co., Ltd.
  • Nanoprobes, Inc.
  • Novavida S.A.
  • Oncotherm Kft.
  • OrienTech Co., Ltd.
  • Perseon Corporation
  • Pyrexar Medical, Inc.
  • RanD S.r.l.
  • Sensius B.V.
  • Shanghai Huayuan Medical Equipment Co., Ltd.
  • Xianke Medical Equipment Co., Ltd.
  • Yamamoto Vinita Co., Ltd.